Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.

Journal of the European Academy of Dermatology and Venereology : JEADV(2023)

Cited 0|Views15
No score
Abstract
The data that support the findings of this study are available from the corresponding author upon reasonable request.
More
Translated text
Key words
severe relapses,treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined